Found 8 matching trials
Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV PHASE1 This Phase I/II study evaluated the pharmacokinetics, safety, and tolerabil...
Show More Location
Byramjee Jeejeebhoy Medical College (BJMC) CRS
Learn More & Join Trial
A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683 PHASE2 A phase 2, multicenter, uncontrolled, open-label trial in participants with...
Show More Location
Beijing Chest Hospital
Learn More & Join Trial
Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis PHASE1 The purpose of this trial is to determine the pediatric dose of delamanid t...
Show More Location
De La Salle Health Sciences Institute
Learn More & Join Trial
Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis PHASE2 The purpose of this study is:
* To evaluate the safety and tolerability of...
Show More Location
Infectology Center of Latvia - Clinic of Tuberculosis and Lung Diseases
Learn More & Join Trial
A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB) PHASE2 The purpose of this trial is to assess the safety, tolerability, pharmacoki...
Show More Location
De La Salle Health Sciences Institute
Learn More & Join Trial
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis PHASE1 The purpose of the study is to evaluate the pharmacokinetics (PK), safety, ...
Show More Location
Site 5071, Instituto de Puericultura e Pediatria Martagao Gesteira CRS
Learn More & Join Trial
Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB PHASE2 Multi-drug-resistant tuberculosis (MDR-TB) affects nearly 600,000 persons e...
Show More Location
Partners in Health
Learn More & Join Trial
A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) PHASE2 This is a clinical trial to evaluate the safety and efficacy of OPC-67683 i...
Show More Location
University of Texas Health Center at Tyler / Heartland National TB Center / Texas Center for Infectious Disease
Learn More & Join Trial